Thorne Healthtech EBIT per Share
Delisted
The EBIT per Share of Thorne Healthtech (THRN) as of Oct 13, 2026 is 0.10 USD. In the previous year, EBIT per Share was 0.17 USD — a change of -37.78% (lower).
Get this data via API
Financial Data API
EBIT per Share
0.10USD
YoY
-37.78%
Last updated:
EBIT per Share of Thorne Healthtech is 2022 0.10 USD. EBIT per Share of Thorne Healthtech was 2021 0.17 USD. It decreases by -37.78% lower compared to the previous year.
The Thorne Healthtech EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-2.02 USD
Jan 1, 2020
0.02 USD
Jan 1, 2021
0.17 USD
Jan 1, 2022
0.10 USD
Jan 1, 2023 (e)
0.45 USD
Jan 1, 2024 (e)
0.91 USD
Jan 1, 2025 (e)
1.26 USD
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 1.26USD | +39.17% |
| est | 0.91USD | +102.11% |
| est | 0.45USD | +334.72% |
| 0.10USD | -37.78% | |
| 0.17USD | +1,004.95% | |
| 0.02USD | -100.75% | |
| -2.02USD | — |
Access this data via the Eulerpool API
Thorne Healthtech Stock analysis
What does Thorne Healthtech do? Thorne Healthtech Inc is a leading company in the health and wellness industry based in the USA. Founded in 1984 by Al Czap, a former Olympic champion and naturopath, Thorne Healthtech Inc has focused on producing high-quality dietary supplements.
The history of Thorne Healthtech Inc began with the goal of improving people's health and well-being. The founder, Czap, believed that it was necessary to strengthen the body from the inside out to achieve long-term health. He started integrating naturopathic principles into his work and developing natural-based dietary supplements.
Thorne Healthtech Inc's business model is based on the development and production of high-quality dietary supplements tailored to the needs of customers. The company has a strong research and development department that constantly develops new innovative products and improves existing ones. Thorne Healthtech Inc adheres to strict quality standards in manufacturing, and the products are produced under the supervision of experts.
The company has divided itself into different divisions to offer customers a wide range of health products. One of the divisions is Performance Products, specifically tailored to athletes. This can include dietary supplements for post-workout recovery, collagen for joint health support, or supplements to enhance endurance and strength.
Another division is Immune System Products. Here, Thorne Healthtech Inc offers a variety of dietary supplements designed to strengthen the immune system and protect the body against diseases and infections. This includes vitamins, herbs, minerals, and probiotic supplements.
Another important area is Nutrient Supplements. Thorne Healthtech Inc produces a wide range of dietary supplements that can help provide the body with the necessary amount of nutrients. These include folic acid, magnesium, vitamin B12, and vitamin C.
A particularly important area for the health industry is the Laboratory Tests sector. Thorne Healthtech Inc offers various tests for interested customers to better understand their health condition. These include tests for vitamins, minerals, probiotics, allergies, and more.
In conclusion, Thorne Healthtech Inc is a company specialized in improving the physical and mental health of people through the production of high-quality dietary supplements. The company has a long history and extensive experience in naturopathy, and follows strict quality standards in product manufacturing. With a wide range of health and wellness products and excellent customer service, Thorne Healthtech Inc aims to support its customers in leading healthier lives. Thorne Healthtech is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Thorne Healthtech stock
EBIT per Share of Thorne Healthtech is 0.10 USD in 2022.
EBIT per Share of Thorne Healthtech changed from 0.17 USD to 0.10 USD, representing a -37.78% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Thorne Healthtech since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Thorne Healthtech
All Key Metrics — Thorne Healthtech
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth